Loading data
BKRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 27.73 bn USD | 27.83 bn USD | 25.51 bn USD | 21.16 bn USD | 20.5 bn USD |
| Research and development expense | 600 m USD | 643 m USD | 651 m USD | 552 m USD | 492 m USD |
| Selling, general and administrative expense | 2.39 bn USD | 2.46 bn USD | 2.61 bn USD | 2.51 bn USD | 2.47 bn USD |
| Operating profit | — | 3.08 bn USD | 2.32 bn USD | 1.19 bn USD | 1.31 bn USD |
| Profit before tax | 2.88 bn USD | 3.27 bn USD | 2.66 bn USD | 22 m USD | 428 m USD |
| Income tax expense | 253 m USD | 257 m USD | 685 m USD | 600 m USD | 758 m USD |
| Net income (reported basis) | 2.59 bn USD | 2.98 bn USD | 1.94 bn USD | -601 m USD | -219 m USD |
| Basic earnings per share | — | 3 USD/share | 1.93 USD/share | -0.61 USD/share | -0.27 USD/share |
| Diluted earnings per share | — | 2.98 USD/share | 1.91 USD/share | -0.61 USD/share | -0.27 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.